ebook Munafa Stock Market Course + Intraday & FNO calls  

       

524816 announcements Natco Pharm announcements and dividends declared BSE

Natco Pharm Complete list of announcements declared & dividend announcements by Natco Pharm 524816

Natco Pharm 524816 listed on BSE and deals in

Announcements and dividends declared by Natco Pharm 524816

Natco Pharma shares drop over 5% after previous day’s double-digit gains
Natco Pharma shares fell as investors booked profits after a sharp rally in the previous session. The stock has been volatile this week, slipping earlier after the US FDA issued seven Form-483 observations at its Manali API plant, which the company said we
Announcement as on 27 November 2025

Natco Pharma shares jump over 5% after three-day slump
Natco Pharma shares surged on Wednesday, bouncing back from a three-day decline that followed a US FDA inspection of its API manufacturing facility in Manali, Chennai, conducted from November 17–21, 2025. The inspection flagged seven Form-483 observations,
Announcement as on 26 November 2025

Patent Row: Delhi HC refuses to ban Natco Pharma's insecticide sale
The Delhi High Court has refused to stop Natco Pharma from selling an insecticide. FMC Corp had alleged patent infringement. The court noted Natco Pharma's strong defense and significant investments. The patent is also nearing expiry. FMC Corp's claims abo
Announcement as on 17 November 2025

Cipla, Natco Pharma, Hetero Labs among Indian firms chosen to supply key generic drugs in China
Indian firms Hetero Labs Limited, Cipla Ltd, Annora Pharma Private Limited and Natco Pharma won the bids conducted by the Chinese health ministry for procurement of pharmaceuticals for its hospitals, according to the India-China Economic and Cultural Counc
Announcement as on 11 November 2025

Delhi HC allows Natco Pharma to launch risdiplam, rejects Roche plea
The Delhi High Court has permitted Natco Pharma to launch its affordable generic version of risdiplam, a crucial drug for spinal muscular atrophy. This decision overturns a previous stay, allowing Natco to offer the medication at a significantly lower pric
Announcement as on 09 October 2025

Announcements by Natco Pharm first page | Next page |

524816 Natco Pharm current price & indicator signals

Moving Averages for Natco Pharm

  • 5Day Average: 930.7
  • 12Day Average: 895.87
  • 20Day Average: 863.53
  • 50Day Average: 839.54
  • 100Day Average: 876.39
  • 150Day Average: 878.73
  • 200Day Average: 878.19

524816 Indicators & signals

Indicator MACD (12,26,9)

900.07, 871.56, 18.57
Indicator MACD is in positive zone

Indicator ADX (14)

43.28, 30.86, 12.22
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 58
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 524816 Natco Pharm are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
05 Fri Dec 2025 933.60 928.80 to 947.15 -1.61% 0.12 times
04 Thu Dec 2025 948.85 910.70 to 950.00 1.53% 0.3 times
03 Wed Dec 2025 934.55 923.50 to 944.40 0.12% 0.49 times
02 Tue Dec 2025 933.45 898.60 to 948.25 3.37% 1.43 times
01 Mon Dec 2025 903.05 879.25 to 922.25 2.82% 1.17 times
28 Fri Nov 2025 878.30 868.75 to 900.00 -0.43% 0.3 times
27 Thu Nov 2025 882.05 876.45 to 933.00 -4.84% 1.3 times
26 Wed Nov 2025 926.90 831.35 to 937.00 11.15% 4.52 times
25 Tue Nov 2025 833.95 827.35 to 850.25 -0.96% 0.18 times
24 Mon Nov 2025 842.05 837.90 to 864.00 -2.59% 0.12 times
21 Fri Nov 2025 864.40 857.00 to 872.05 -0.56% 0.19 times
20 Thu Nov 2025 869.30 828.45 to 887.60 4.72% 0.91 times

Videos related to: 524816 announcements Natco Pharm announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

524816 announcements Natco Pharm announcements and dividends declared BSE

 

Back to top